Clinical trials
Phase 2 Fibrosis trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 1 |
| Mediar Therapeutics | 1 |
| Pulmovant, Inc. | 1 |
| University of Sao Paulo General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 4 |
| Idiopathic Pulmonary Fibrosis | 2 |
| Lung Diseases | 2 |
| Lung Diseases, Interstitial | 2 |
| Cardiovascular Diseases | 1 |
| Chagas Disease | 1 |
| Hypertension, Pulmonary | 1 |
| Idiopathic Interstitial Pneumonias | 1 |
| Inflammation | 1 |
| Pathologic Processes | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.